Shanghai No.1 Pharmacy Co., Ltd.

Symbol: 600833.SS

SHH

10.6

CNY

Market price today

  • 27.0851

    P/E Ratio

  • 3.3571

    PEG Ratio

  • 2.36B

    MRK Cap

  • 0.02%

    DIV Yield

Shanghai No.1 Pharmacy Co., Ltd. (600833-SS) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.18%

Operating Profit Margin

0.01%

Net Profit Margin

0.05%

Return on Assets

0.05%

Return on Equity

0.09%

Return on Capital Employed

0.02%

Company general description and statistics

Sector: Healthcare
Industry: Pharmaceuticals - Retailers
CEO:Mr. Jun Yao
Full-time employees:877
City:Shanghai
Address:681 Xiaomuqiao Road
IPO:1994-02-24
CIK:

Shanghai No.1 Pharmacy Co., Ltd. engages in the retail and wholesale of pharmaceutical products. The company offers products in the categories of Chinese and Western medicines, nutrition and health products, medical equipment, Chinese herbal medicines, etc. In addition, it provides consulting and guidance on safe medication, rational medication, and chronic disease medication. Shanghai No. 1 Pharmacy Co., Ltd. is based in Shanghai, China.

General Outlook

When we look at how much money they make before expenses, they keep 0.178% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.013%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.053%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.052% return, is a testament to Shanghai No.1 Pharmacy Co., Ltd.'s adeptness in optimizing resource deployment. Shanghai No.1 Pharmacy Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.095%. Furthermore, the proficiency of Shanghai No.1 Pharmacy Co., Ltd. in capital utilization is underscored by a remarkable 0.019% return on capital employed.

Stock Prices

Shanghai No.1 Pharmacy Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $11.13, while its low point bottomed out at $10.9. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Shanghai No.1 Pharmacy Co., Ltd.'s stock market.

Liquidity Ratios

Analyzing 600833.SS liquidity ratios reveals its financial health of the firm. The current ratio of 168.86% gauges short-term asset coverage for liabilities. The quick ratio (107.55%) assesses immediate liquidity, while the cash ratio (61.70%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio168.86%
Quick Ratio107.55%
Cash Ratio61.70%

Profitability Ratios

600833.SS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 6.96% underscores its earnings before tax deductions. The effective tax rate stands at 24.38%, revealing its tax efficiency. The net income per EBT, 75.62%, and the EBT per EBIT, 535.48%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 1.30%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin6.96%
Effective Tax Rate24.38%
Net Income per EBT75.62%
EBT per EBIT535.48%
EBIT per Revenue1.30%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.69, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 669.87% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding108
Days of Inventory Outstanding79
Operating Cycle133.96
Days of Payables Outstanding90
Cash Conversion Cycle44
Receivables Turnover6.70
Payables Turnover4.07
Inventory Turnover4.59
Fixed Asset Turnover7.92
Asset Turnover0.98

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.11, and free cash flow per share, -0.26, depict cash generation on a per-share basis. The cash per share value, 1.85, showcases liquidity position. A payout ratio of 0.49 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, -0.01, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.11
Free Cash Flow per Share-0.26
Cash per Share1.85
Payout Ratio0.49
Operating Cash Flow Sales Ratio-0.01
Free Cash Flow to Operating Cash Flow Ratio2.50
Cash Flow Coverage Ratio-0.09
Short Term Coverage Ratio-0.14
Capital Expenditure Coverage Ratio-0.67
Dividend Paid and Capex Coverage Ratio-0.29
Dividend Payout Ratio0.02

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 14.87%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.27, we discern the balance between debt and equity financing. The long-term debt to capitalization, 9.01%, and total debt to capitalization, 20.99%, ratios shed light on its capital structure. An interest coverage of 4.03 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio14.87%
Debt Equity Ratio0.27
Long Term Debt to Capitalization9.01%
Total Debt to Capitalization20.99%
Interest Coverage4.03
Cash Flow to Debt Ratio-0.09
Company Equity Multiplier1.79

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 8.12, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.40, reflects the portion of profit attributed to each share. The book value per share, 4.49, represents the net asset value distributed per share, while the tangible book value per share, 4.39, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share8.12
Net Income Per Share0.40
Book Value Per Share4.49
Tangible Book Value Per Share4.39
Shareholders Equity Per Share4.49
Interest Debt Per Share1.50
Capex Per Share-0.06

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -31.81%, indicates top-line expansion, while the gross profit growth, -46.79%, reveals profitability trends. EBIT growth, -95.47%, and operating income growth, -95.47%, offer insights into operational profitability progression. The net income growth, -37.81%, showcases bottom-line expansion, and the EPS growth, -37.50%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-31.81%
Gross Profit Growth-46.79%
EBIT Growth-95.47%
Operating Income Growth-95.47%
Net Income Growth-37.81%
EPS Growth-37.50%
EPS Diluted Growth-37.50%
Dividends per Share Growth75.79%
Operating Cash Flow Growth-37.85%
Free Cash Flow Growth-43.48%
10-Year Revenue Growth per Share37.55%
5-Year Revenue Growth per Share53.92%
3-Year Revenue Growth per Share14.13%
10-Year Operating CF Growth per Share1191.49%
5-Year Operating CF Growth per Share92.15%
3-Year Operating CF Growth per Share-2.39%
10-Year Net Income Growth per Share166.79%
5-Year Net Income Growth per Share89.20%
3-Year Net Income Growth per Share30.25%
10-Year Shareholders Equity Growth per Share93.81%
5-Year Shareholders Equity Growth per Share51.15%
3-Year Shareholders Equity Growth per Share34.91%
10-Year Dividend per Share Growth per Share342.40%
5-Year Dividend per Share Growth per Share259.97%
3-Year Dividend per Share Growth per Share163.22%
Receivables Growth-5.03%
Inventory Growth-0.75%
Asset Growth-8.63%
Book Value per Share Growth5.23%
Debt Growth-28.65%
SGA Expenses Growth16.72%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 2,597,225,347.59, captures the company's total value, considering both debt and equity. Income quality, 0.92, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 2.24%, indicates the value of non-physical assets, and capex to operating cash flow, -16.88%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value2,597,225,347.59
Income Quality0.92
Sales General and Administrative to Revenue0.01
Intangibles to Total Assets2.24%
Capex to Operating Cash Flow-16.88%
Capex to Revenue-0.77%
Capex to Depreciation-23.21%
Graham Number6.36
Return on Tangible Assets4.90%
Graham Net Net0.13
Working Capital440,443,452
Tangible Asset Value979,214,535
Net Current Asset Value274,952,772
Average Receivables285,829,012.5
Average Payables351,001,018.5
Average Inventory333,493,219
Days Sales Outstanding56
Days Payables Outstanding81
Days of Inventory On Hand80
ROIC0.50%
ROE0.09%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.50, and the price to book ratio, 2.50, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.43, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -44.30, and price to operating cash flows, -110.54, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio2.50
Price to Book Ratio2.50
Price to Sales Ratio1.43
Price Cash Flow Ratio-110.54
Price Earnings to Growth Ratio3.36
Enterprise Value Multiple36.17
Price Fair Value2.50
Price to Operating Cash Flow Ratio-110.54
Price to Free Cash Flows Ratio-44.30
Price to Tangible Book Ratio2.67
Enterprise Value to Sales1.43
Enterprise Value Over EBITDA37.96
EV to Operating Cash Flow31.59
Earnings Yield3.34%
Free Cash Flow Yield2.56%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Shanghai No.1 Pharmacy Co., Ltd. (600833.SS) on the SHH in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 27.085 in 2024.

What is the ticker symbol of Shanghai No.1 Pharmacy Co., Ltd. stock?

The ticker symbol of Shanghai No.1 Pharmacy Co., Ltd. stock is 600833.SS.

What is company IPO date?

IPO date of Shanghai No.1 Pharmacy Co., Ltd. is 1994-02-24.

What is company current share price?

Current share price is 10.600 CNY.

What is stock market cap today?

The market cap of stock today is 2364711600.000.

What is PEG ratio in 2024?

The current 3.357 is 3.357 in 2024.

What is the number of employees in 2024?

In 2024 the company has 877.